The same blood-cancer tablet, ibrutinib 420 mg once a day — priced from official databases in six places.
Researched with AI assistance; every figure is checked against the primary source cited on this page before publishing. How we work →
Imbruvica 420 mg, one tablet a day, so 30 days = 30 tablets. Each country's own official price; where the official pack has 28 tablets, we convert to 30 (our calculation: pack price ÷ 28 × 30). The US Medicare figure is CMS's price per tablet × 30 (our calculation). US dollars at European Central Bank reference rates of October 30, 2026.
IMBRUVICA (IBRUTINIB) 420 MG · 30 DAYS = 30 TABLETS
Price by country, November 2026
Packs of 28 converted to 30 tablets; US Medicare = CMS price per tablet × 30 (our calculation). No US pharmacy-cost survey figure exists for this drug.
| Country | Official price | 30 days in US dollars | What a patient typically pays |
|---|---|---|---|
| 🇺🇸 United States (Medicare) | $9,319 negotiated price per 30-day supply, since Jan 1, 2026; $353.98 per 420 mg tablet (CMS price file); 2023 list price $14,934 | $10,619 for 30 tablets | Depends on the Part D plan; out-of-pocket costs are capped each year |
| 🇺🇸 United States (pharmacy cost) | No ibrutinib row in CMS NADAC (Oct 28, 2026) | — | — |
| 🇬🇧 United Kingdom | £4,292.40 for 28 tablets (NHS price, since July 11, 2019; hospital-only pack) | $6,162 | Usually supplied through the hospital |
| 🇫🇷 France | €4,289.07 for 30 tablets (official price excluding dispensing fee) | $4,792 | Fully reimbursed (100%) |
| 🇨🇭 Switzerland | CHF 4,494.50 for 28 tablets (public price) | $5,852 | 10% share after the annual deductible |
| 🇦🇹 Austria | €4,934.75 for 28 tablets (social-insurance price excl. VAT; effective price may be lower under a price model) | $5,907 | €7.55 prescription fee per pack; insurer approval needed first |
| 🇳🇱 Netherlands | €5,595.93 for 30 tablets (average pharmacy price) | $6,252 | Reimbursed under conditions; counts toward the annual deductible |
| 🇩🇪 Germany | No statutory price ceiling (Festbetrag) for ibrutinib | — | €10 co-payment per pack (10%, max. €10) |
We compare prices; we do not recommend where to buy medicine. Cancer treatment decisions belong with your oncologist or haematologist.
Imbruvica's negotiated price is $9,319 for a 30-day supply, 38% below the 2023 list price of $14,934 — the smallest reduction among the ten drugs in the first round (CMS). CMS's price file sets $353.98 per 420 mg tablet for 2026 and $363.55 from January 1, 2027 after an inflation adjustment. Medicare Part D caps a patient's yearly out-of-pocket drug costs; the cap amount is set by CMS each year.
For 30 tablets of 420 mg, France lists €4,289.07 and the Netherlands €5,595.93; for 28 tablets the UK lists £4,292.40 and Switzerland CHF 4,494.50. Converted to 30 tablets at ECB rates that is about $4,800 to $6,250 — roughly 45% to 59% of the $10,619 that Medicare's per-tablet price adds up to (our calculation).
Ibrutinib is not on the German statutory price-ceiling (Festbetrag) list of October 15, 2026. We found no current, freely published official pharmacy price, so we show none. Insured patients pay a 10% co-payment, capped at €10 per pack (€15 from 2027).
Medicare has paid a negotiated $9,319 for a 30-day supply of Imbruvica since January 1, 2026; the 2023 list price was $14,934 (CMS). CMS's price file sets $353.98 per 420 mg tablet. Official prices elsewhere: €4,289.07 for 30 tablets in France, €5,595.93 in the Netherlands, £4,292.40 for 28 in the UK and CHF 4,494.50 for 28 in Switzerland — roughly $4,800 to $6,250 for 30 tablets at ECB rates.
The CMS survey of what pharmacies pay (NADAC, October 28, 2026) has no row for ibrutinib; specialty drugs dispensed through specialty pharmacies are often missing from it. We also could not verify a current US list price from the maker.
We found no generic ibrutinib in the official lists we checked (US NADAC, UK dm+d, France, Switzerland, the Netherlands).
In France Imbruvica is reimbursed at 100%. In Germany statutory insurance covers it with a 10% co-payment, capped at €10 per pack. In Switzerland insured patients pay a 10% share after their deductible. In the UK the pack is hospital-only. In the US it depends on the plan; Medicare Part D caps yearly out-of-pocket costs.
Yes, slightly: CMS's price file adjusts it for inflation to $9,571.07 for a 30-day supply and $363.55 per 420 mg tablet from January 1, 2027.
Wellness Vision does not sell medicine, recommend pharmacies or suppliers, or take payments from drug makers. Every price above comes from the official source cited; conversions and per-30-tablet figures are our own calculations, shown with their formula. This is a cost comparison, not medical advice.
You shouldn't have to go broke to feel whole.
